Sands Capital Ventures, LLC Dice Therapeutics, Inc. Transaction History

Sands Capital Ventures, LLC

  • $199 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
SELL
$19.77 - $42.23 $7.91 Million - $16.9 Million
-400,000 Reduced 12.7%
2,748,970 $85.8 Million
Q3 2021

Nov 04, 2021
BUY
$31.92 - $37.0 $101 Million - $117 Million
3,148,970 New
3,148,970 $103 Million

Others Institutions Holding DICE

# of Institutions
3
Shares Held
17.7K
Call Options Held
13K
Put Options Held
0
View Full List

About DICE Therapeutics, Inc.

DICE Quotes by TradingView
  • Ticker DICE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,430,000
  • Description
  • DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...
More about DICE
Track This Portfolio

Track Sands Capital Ventures, LLC Portfolio

Follow Sands Capital Ventures, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sands Capital Ventures, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sands Capital Ventures, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email